Vista Partners Updates Coverage on AUXILIO Inc.; $3.35 Target Price

Wed Dec 5, 2012 9:00am EST

* Reuters is not responsible for the content in this press release.

  SAN FRANCISCO, CA, Dec 05 (Marketwire) -- 
Vista Partners announced today that it has updated coverage on AUXILIO
Inc. (OTCBB: AUXO) ("The Company," "AUXILIO" or "AUXO"); and maintains
its twelve month target price of $3.35. Ross Silver, Principal Analyst at
Vista Partners, stated, "Between December 2011 and June 2012, AUXILIO
signed contracts worth an estimated $90 million in new service revenue
over the life of the contracts which are all five years. The contracts
represent 45 hospitals including some of the nation's most prestigious
health care provider organizations and health care systems." Mr. Silver
concludes, "AUXILIO announced in August that it expects revenue growth in
excess of 50% in 2012, based solely on contracts closed since December
2011. In the recent third quarter earnings release, the Company stated
that it expects to reach cash flow positive from operations during 2013.
Should both of these occur we believe it would serve as a catalyst to the
share price and enhance AUXILIO's position of potentially being targeted
as an acquisition candidate."

    To download a FREE copy of the AUXILIO Inc. research report, please visit
http://www.vistapglobal.com and click the "download research" icon to
gain access to the report. 

    About Vista Partners:
 Vista Partners LLC, founded in 2005, is a
Registered Investment Advisor in the States of California and Oregon. The
firm's professional staff has backgrounds in finance, corporate
communications and investment banking.

    Please follow us on Twitter @VistaPResearch & Facebook at Vista-Partners
to receive updates, thoughts and ideas about our coverage universe of
companies.

    Disclaimer & Disclosure:
 For a full list of disclaimers and disclosures,
please visit our website www.vistapglobal.com or click here. 

    

Contact:
877.215.4813
info@vistapglobal.com 

Copyright 2012, Marketwire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.